Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tick-borne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction

Journal of Neurology

Volumn 247, Issue 8, 2000, Pages 636-642

  Studahl, Marie ^a   Rosengren, Lars ^a   Günther, Göran ^b   Hagberg, Lars ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cerebrospinal fluid; Herpes simplex encephalitis; Neurofilament protein; Neuron specific enolase; Tick borne encephalitis

Indexed keywords

BIOLOGICAL MARKER; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROFILAMENT PROTEIN; NEURON SPECIFIC ENOLASE; PROTEIN S 100;

ADULT; AGED; ARTICLE; CELL DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLIA CELL; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; HUMAN; MALE; NERVE CELL LESION; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SYMPTOMATOLOGY; TICK BORNE ENCEPHALITIS;

ADULT; AGED; BIOLOGICAL MARKERS; ENCEPHALITIS, HERPES SIMPLEX; ENCEPHALITIS, TICK-BORNE; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HERPESVIRUS 1, HUMAN; HUMANS; MALE; MIDDLE AGED; NEUROFILAMENT PROTEINS; NEUROGLIA; NEURONS; PHOSPHOPYRUVATE HYDRATASE; S100 PROTEINS;

EID: 0033812907     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150070134     Document Type: Article

References (38)

1. Acute encephalitis
2. Acute encephalitis
3. Acute viral encephalitis, its diagnosis and outcome
4. Encephalitis, a four-year survey
5. Diseases that mimic herpes simplex encephalitis
6. Sporadic encephalitis
7. Herpes simplex encephalitis
8. Herpes simplex encephalitis treated with acyclovir: Diagnosis and long term outcome
9. Tick-borne encephalitis in Sweden in relation to aseptic meningo-encephalitis of other etiology: A prospective study of clinical course and outcome
10. Studying the intrinsic determinants of neuronal form and function
11. Molecular and cellular biology of intermediate filaments
12. Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF
13. Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells
14. Quantitative alterations of S-100 protein and neuron specific enolase in the rat nervous system after chronic 2,5 hexanedione exposure
15. Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases
16. Cerebrospinal fluid enolase in stroke
17. Neuron-specific enolase in patients with acute ischemic stroke and related dementia
18. Glial fibrillary acidic protein (GFAP): The major protein of glial intermediate filament in differentiated astrocytes
19. Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction
20. A sensitive ELISA for glial fibrillary acidic protein: Application in CSF of adults
21. A rapid separation of S-100 subunits by high performance liquid chromatography: The subunit composition of S-100 proteins
22. Production and characterization of monoclonal antibodies against the 'brain-specific' proteins 14-13 2 and S-100
23. Monotoring and tentative diagnosis of herpetic encephalitis by protein analysis of cerebrospinal fluid. Particular relevance of the assays of ferritin and S-100
24. Acute viral encephalitis in adults - A prospective study
25. Assessment of outcome after severe brain damage
26. Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid
27. Comparison of two different enzyme immunoassays for detection of immunoglobulin M antibodies against tick-borne encephalitis virus in serum and cerebrospinal fluid
28. The histopathology of tick-borne encephalitis
29. Intrathecal production of neopterin and beta-2 microglobulin in tick-borne encephalitis (TBE) compared to meningoencephalitis of other etiology
30. Identification of tick-borne encephalitis virus ribonucleic acid in tick suspensions and in clinical specimens by a reverse transcription-nested polymerase chain reaction assay
31. Neurofilament protein in cerebrospinal fluid: A potential marker of activity in multiple sclerosis
32. MRI demonstrations of Wallerian degeneration in various intracranial lesions and its clinical implications
33. Immunosuppressive measles encephalitis
34. Persistent intrathecal immune activation in patients with herpes simplex encephalitis
35. Cytokines and other markers of intrathecal immune response in patients with herpes simplex encephalitis
36. Long-term persistence of intrathecal virus-specific antibody responses after herpes simplex virus encephalitis
37. Glial fibrillary acidic protein in the cerebrospinal fluid: A possible indicator of prognosis in full-term asphyxiated newborn-infants?
38. CSF and serum brain-specific creatine kinase isoenzyme (CK-BB), neuron-specific enolase (NSE) and neural cell adhesion molecule (NCAM) as prognostic markers for hypoxic brain injury after cardiac arrest in man